Home > Publications database > The manifestation of affective symptoms in multiple sclerosis and discussion of the currently available diagnostic assessment tools > print

001     912532
005     20231027114348.0
024 7 _ |2 doi
|a 10.1007/s00415-022-11359-6
024 7 _ |2 ISSN
|a 0012-1037
024 7 _ |2 ISSN
|a 0340-5354
024 7 _ |2 ISSN
|a 0939-1517
024 7 _ |2 ISSN
|a 1432-1459
024 7 _ |2 ISSN
|a 1619-800X
024 7 _ |2 Handle
|a 2128/33918
024 7 _ |2 pmid
|a 36129540
024 7 _ |2 WOS
|a WOS:000858335900001
037 _ _ |a FZJ-2022-05705
082 _ _ |a 610
100 1 _ |0 P:(DE-HGF)0
|a Filser, Melanie
|b 0
245 _ _ |a The manifestation of affective symptoms in multiple sclerosis and discussion of the currently available diagnostic assessment tools
260 _ _ |a Berlin
|b Springer
|c 2023
264 _ 1 |2 Crossref
|3 online
|b Springer Science and Business Media LLC
|c 2022-09-21
264 _ 1 |2 Crossref
|3 print
|b Springer Science and Business Media LLC
|c 2023-01-01
264 _ 1 |2 Crossref
|3 print
|b Springer Science and Business Media LLC
|c 2023-01-01
336 7 _ |2 DRIVER
|a article
336 7 _ |2 DataCite
|a Output Types/Journal article
336 7 _ |0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|a Journal Article
|b journal
|m journal
|s 1676551935_6239
336 7 _ |2 BibTeX
|a ARTICLE
336 7 _ |2 ORCID
|a JOURNAL_ARTICLE
336 7 _ |0 0
|2 EndNote
|a Journal Article
520 _ _ |a AbstractIntroduction In addition to physical and cognitive symptoms, patients with multiple sclerosis (MS) have an increased riskof experiencing mental health problems.Methods This narrative review provides an overview of the appearance and epidemiology of affective symptoms in MS suchas depression, anxiety, bipolar disorder, euphoria, and pseudobulbar affect. Furthermore, the association between affectivesymptoms and quality of life and the currently used diagnostic instruments for assessing these symptoms are consideredwhereby relevant studies published between 2009 and 2021 were included in the review.Results Patients with mild and moderate disability more frequently reported severe problems with depression and anxietythan severe mobility problems. Apart from the occurrence of depression, little is known about the association of other affectivesymptoms such as anxiety, bipolar disorder, euphoria, and pseudobulbar affect and subsyndromal symptoms, which failto meet the diagnostic criteria but are nevertheless a significant source of distress. Although there are a few recommendationsin the research to perform routine screenings for diagnosable affective disorders, a standardized diagnostic procedureto assess subsyndromal symptoms is still lacking. As the applied measurements are diverse and show low accuracy to detectthese symptoms, patients who experience affective symptoms are less likely to be identified.Discussion In addition to the consideration of definite psychiatric diagnoses, there is an unmet need for a common definitionand assessment of disease-related affective symptoms in MS. Future studies should focus on the improvement andstandardization of a common diagnostic procedure for subsyndromal affective symptoms in MS to enable integrated andoptimal care for patients.Keywords Multiple sclerosis · Affective symptoms · Mental health · Diagnostic assessment tools · Quality of life
536 _ _ |0 G:(DE-HGF)POF4-5251
|a 5251 - Multilevel Brain Organization and Variability (POF4-525)
|c POF4-525
|f POF IV
|x 0
542 _ _ |2 Crossref
|i 2022-09-21
|u https://creativecommons.org/licenses/by/4.0
542 _ _ |2 Crossref
|i 2022-09-21
|u https://creativecommons.org/licenses/by/4.0
588 _ _ |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de
700 1 _ |0 P:(DE-HGF)0
|a Buchner, Axel
|b 1
700 1 _ |0 P:(DE-Juel1)131720
|a Fink, Gereon Rudolf
|b 2
|u fzj
700 1 _ |0 P:(DE-HGF)0
|a Gold, Stefan M.
|b 3
700 1 _ |0 0000-0002-6746-1034
|a Penner, Iris-Katharina
|b 4
|e Corresponding author
773 1 8 |2 Crossref
|3 journal-article
|a 10.1007/s00415-022-11359-6
|b Springer Science and Business Media LLC
|d 2022-09-21
|n 1
|p 171-207
|t Journal of Neurology
|v 270
|x 0340-5354
|y 2023
773 _ _ |0 PERI:(DE-600)1421299-7
|a 10.1007/s00415-022-11359-6
|g Vol. 270, no. 1, p. 171 - 207
|n 1
|p 171-207
|t Journal of neurology
|v 270
|x 0340-5354
|y 2023
856 4 _ |u https://juser.fz-juelich.de/record/912532/files/PDF.pdf
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/912532/files/post-print.pdf
|y OpenAccess
909 C O |o oai:juser.fz-juelich.de:912532
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)131720
|a Forschungszentrum Jülich
|b 2
|k FZJ
913 1 _ |0 G:(DE-HGF)POF4-525
|1 G:(DE-HGF)POF4-520
|2 G:(DE-HGF)POF4-500
|3 G:(DE-HGF)POF4
|4 G:(DE-HGF)POF
|9 G:(DE-HGF)POF4-5251
|a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|v Decoding Brain Organization and Dysfunction
|x 0
914 1 _ |y 2023
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-10-21
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-21
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J NEUROL : 2022
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-10-21
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-10-21
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b J NEUROL : 2022
|d 2023-10-21
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-3-20090406
|k INM-3
|l Kognitive Neurowissenschaften
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)INM-3-20090406
980 1 _ |a FullTexts
999 C 5 |1 PA Arnett
|2 Crossref
|9 -- missing cx lookup --
|a 10.1586/ern.11.12
|p 411 -
|t Expert Rev Neurother
|u Arnett PA, Strober LB (2011) Cognitive and neurobehavioral features in multiple sclerosis. Expert Rev Neurother 11:411–424. https://doi.org/10.1586/ern.11.12
|v 11
|y 2011
999 C 5 |1 R Leonavičius
|2 Crossref
|9 -- missing cx lookup --
|a 10.2478/s11536-012-0032-x
|p 685 -
|t Open Med
|u Leonavičius R, Adomaitienė V (2012) Impact of depression on multiple sclerosis patients. Open Med 7:685–690. https://doi.org/10.2478/s11536-012-0032-x
|v 7
|y 2012
999 C 5 |1 P Flachenecker
|2 Crossref
|9 -- missing cx lookup --
|a 10.1177/1352458517708141
|p 78 -
|t Mult Scler J
|u Flachenecker P, Kobelt G, Berg J et al (2017) New insights into the burden and costs of multiple sclerosis in Europe: results for Germany. Mult Scler J 23:78–90. https://doi.org/10.1177/1352458517708141
|v 23
|y 2017
999 C 5 |1 A Fromont
|2 Crossref
|9 -- missing cx lookup --
|a 10.1007/s00415-013-7041-9
|p 2629 -
|t J Neurol
|u Fromont A, Binquet C, Rollot F et al (2013) Comorbidities at multiple sclerosis diagnosis. J Neurol 260:2629–2637. https://doi.org/10.1007/s00415-013-7041-9
|v 260
|y 2013
999 C 5 |1 RA Marrie
|2 Crossref
|9 -- missing cx lookup --
|a 10.1177/1352458514564487
|p 305 -
|t Mult Scler J
|u Marrie RA, Reingold S, Cohen J et al (2015) The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review. Mult Scler J 21:305–317. https://doi.org/10.1177/1352458514564487
|v 21
|y 2015
999 C 5 |1 RA Marrie
|2 Crossref
|9 -- missing cx lookup --
|a 10.1212/WNL.0000000000002174
|p 1972 -
|t Neurology
|u Marrie RA, Fisk JD, Tremlett H et al (2015) Differences in the burden of psychiatric comorbidity in MS vs the general population. Neurology 85:1972–1979. https://doi.org/10.1212/WNL.0000000000002174
|v 85
|y 2015
999 C 5 |1 RA Marrie
|2 Crossref
|9 -- missing cx lookup --
|a 10.1186/1471-2377-13-16
|p 1 -
|t BMC Neurol
|u Marrie RA, Fisk JD, Yu BN et al (2013) Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance. BMC Neurol 13:1–8. https://doi.org/10.1186/1471-2377-13-16
|v 13
|y 2013
999 C 5 |1 F Jacobi
|2 Crossref
|9 -- missing cx lookup --
|a 10.1007/s00115-013-3961-y
|p 77 -
|t Nervenarzt
|u Jacobi F, Höfler M, Strehle J et al (2014) Psychische Störungen in der Allgemeinbevölkerung. Studie zur Gesundheit Erwachsener in Deutschland und ihr Zusatzmodul Psychische Gesundheit (DEGS1-MH). Nervenarzt 85:77–87. https://doi.org/10.1007/s00115-013-3961-y
|v 85
|y 2014
999 C 5 |1 RA Marrie
|2 Crossref
|9 -- missing cx lookup --
|a 10.1186/s13104-017-2958-1
|p 1 -
|t BMC Res Notes
|u Marrie RA, Walld R, Bolton JM et al (2017) Estimating annual prevalence of depression and anxiety disorder in multiple sclerosis using administrative data. BMC Res Notes 10:1–6. https://doi.org/10.1186/s13104-017-2958-1
|v 10
|y 2017
999 C 5 |1 C Silveira
|2 Crossref
|9 -- missing cx lookup --
|a 10.30773/pi.2019.0106
|p 877 -
|t Psychiatry Investig
|u Silveira C, Guedes R, Maia D et al (2019) Neuropsychiatric symptoms of multiple sclerosis: state of the art. Psychiatry Investig 16:877–888. https://doi.org/10.30773/pi.2019.0106
|v 16
|y 2019
999 C 5 |1 E Longinetti
|2 Crossref
|9 -- missing cx lookup --
|a 10.1177/13524585211031128
|p 632 -
|t Mult Scler J
|u Longinetti E, Frisell T, Englund S et al (2022) Risk of depression in multiple sclerosis across disease-modifying therapies. Mult Scler J 28:632–641. https://doi.org/10.1177/13524585211031128
|v 28
|y 2022
999 C 5 |1 R Murphy
|2 Crossref
|9 -- missing cx lookup --
|a 10.1136/jnnp-2016-315367
|p 697 -
|t J Neurol Neurosurg Psychiatry
|u Murphy R, O’Donoghue S, Counihan T et al (2017) Neuropsychiatric syndromes of multiple sclerosis. J Neurol Neurosurg Psychiatry 88:697–708. https://doi.org/10.1136/jnnp-2016-315367
|v 88
|y 2017
999 C 5 |1 S Roy
|2 Crossref
|9 -- missing cx lookup --
|a 10.1177/1352458515597570
|p 569 -
|t Mult Scler J
|u Roy S, Rodgers J, Drake AS et al (2016) Stable neuropsychiatric status in multiple sclerosis: a 3-year study. Mult Scler J 22:569–574. https://doi.org/10.1177/1352458515597570
|v 22
|y 2016
999 C 5 |1 G Disanto
|2 Crossref
|9 -- missing cx lookup --
|a 10.1002/ana.25247
|p 1162 -
|t Ann Neurol
|u Disanto G, Zecca C, MacLachlan S et al (2018) Prodromal symptoms of multiple sclerosis in primary care. Ann Neurol 83:1162–1173. https://doi.org/10.1002/ana.25247
|v 83
|y 2018
999 C 5 |1 JMA Wijnands
|2 Crossref
|9 -- missing cx lookup --
|a 10.1177/1352458518783662
|p 1092 -
|t Mult Scler J
|u Wijnands JMA, Zhu F, Kingwell E et al (2019) Five years before multiple sclerosis onset: phenotyping the prodrome. Mult Scler J 25:1092–1101. https://doi.org/10.1177/1352458518783662
|v 25
|y 2019
999 C 5 |1 F Caceres
|2 Crossref
|9 -- missing cx lookup --
|a 10.1016/j.msard.2013.10.007
|p 335 -
|t Mult Scler Relat Disord
|u Caceres F, Vanotti S, Benedict RHB et al (2014) Cognitive and neuropsychiatric disorders among multiple sclerosis patients from Latin America: results of the RELACCEM study. Mult Scler Relat Disord 3:335–340. https://doi.org/10.1016/j.msard.2013.10.007
|v 3
|y 2014
999 C 5 |1 H Song
|2 Crossref
|9 -- missing cx lookup --
|a 10.1001/jama.2018.7028
|p 2388 -
|t J Am Med Assoc
|u Song H, Fang F, Tomasson G et al (2018) Association of stress-related disorders with subsequent autoimmune disease. J Am Med Assoc 319:2388–2400. https://doi.org/10.1001/jama.2018.7028
|v 319
|y 2018
999 C 5 |1 ME Benros
|2 Crossref
|9 -- missing cx lookup --
|a 10.1001/jamapsychiatry.2013.1111
|p 812 -
|t JAMA Psychiat
|u Benros ME, Waltoft BL, Nordentoft M et al (2013) Autoimmune diseases and severe infections as risk factors for mood disorders a nationwide study. JAMA Psychiat 70:812–820. https://doi.org/10.1001/jamapsychiatry.2013.1111
|v 70
|y 2013
999 C 5 |1 S Roy
|2 Crossref
|9 -- missing cx lookup --
|a 10.1177/1352458517753720
|t Mult Scler J
|u Roy S, Drake A, Fuchs T et al (2018) Longitudinal personality change associated with cognitive decline in multiple sclerosis. Mult Scler J. https://doi.org/10.1177/1352458517753720
|y 2018
999 C 5 |1 RA Marrie
|2 Crossref
|9 -- missing cx lookup --
|a 10.7224/1537-2073.2016-110
|p 76 -
|t Int J MS Care
|u Marrie RA, Patten SB, Berrigan LI et al (2018) Diagnoses of depression and anxiety versus current symptoms and quality of life in multiple sclerosis. Int J MS Care 20:76–84. https://doi.org/10.7224/1537-2073.2016-110
|v 20
|y 2018
999 C 5 |1 RA Marrie
|2 Crossref
|9 -- missing cx lookup --
|a 10.1177/1352458508099477
|p 385 -
|t Mult Scler
|u Marrie RA, Horwitz R, Cutter G et al (2009) The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated. Mult Scler 15:385–392. https://doi.org/10.1177/1352458508099477
|v 15
|y 2009
999 C 5 |1 RC Kessler
|2 Crossref
|9 -- missing cx lookup --
|a 10.1146/annurev-publhealth-031912-114409
|p 119 -
|t Annu Rev Public Health
|u Kessler RC, Bromet EJ (2013) The epidemiology of depression across cultures. Annu Rev Public Health 34:119–138. https://doi.org/10.1146/annurev-publhealth-031912-114409
|v 34
|y 2013
999 C 5 |1 RJ Simpson
|2 Crossref
|9 -- missing cx lookup --
|a 10.1186/1471-2377-14-128
|p 1 -
|t BMC Neurol
|u Simpson RJ, McLean G, Guthrie B et al (2014) Physical and mental health comorbidity is common in people with multiple sclerosis: nationally representative cross-sectional population database analysis. BMC Neurol 14:1–8. https://doi.org/10.1186/1471-2377-14-128
|v 14
|y 2014
999 C 5 |1 B Brokate
|2 Crossref
|9 -- missing cx lookup --
|a 10.1024/1016-264X/a000203
|p 197 -
|t Zeitschrift für Neuropsychol
|u Brokate B, Reimer J, Hildebrandt H (2017) Charakteristik depressiver Symptome bei psychischen Erkrankungen und Multipler Sklerose – eine retrospektive Datenanalyse. Zeitschrift für Neuropsychol 28:197–205. https://doi.org/10.1024/1016-264X/a000203
|v 28
|y 2017
999 C 5 |1 PG Ozdemir
|2 Crossref
|9 -- missing cx lookup --
|a 10.3109/13651501.2014.980831
|p 148 -
|t Int J Psychiatry Clin Pract
|u Ozdemir PG, Milanlioglu A, Boysan M et al (2015) Relations between mood characteristics, circadian preferences, and functionality in multiple sclerosis. Int J Psychiatry Clin Pract 19:148–154. https://doi.org/10.3109/13651501.2014.980831
|v 19
|y 2015
999 C 5 |1 T Paparrigopoulos
|2 Crossref
|9 -- missing cx lookup --
|a 10.3109/09540261003589323
|p 14 -
|t Int Rev Psychiatry
|u Paparrigopoulos T, Ferentinos P, Kouzoupis A et al (2010) The neuropsychiatry of multiple sclerosis: focus on disorders of mood, affect and behaviour. Int Rev Psychiatry 22:14–21. https://doi.org/10.3109/09540261003589323
|v 22
|y 2010
999 C 5 |1 A Feinstein
|2 Crossref
|9 -- missing cx lookup --
|a 10.1038/nrneurol.2014.139
|p 507 -
|t Nat Rev Neurol
|u Feinstein A, Magalhaes S, Richard JF et al (2014) The link between multiple sclerosis and depression. Nat Rev Neurol 10:507–517. https://doi.org/10.1038/nrneurol.2014.139
|v 10
|y 2014
999 C 5 |1 SB Patten
|2 Crossref
|9 -- missing cx lookup --
|a 10.1080/09540261.2017.1322555
|p 463 -
|t Int Rev Psychiatry
|u Patten SB, Marrie RA, Carta MG (2017) Depression in multiple sclerosis. Int Rev Psychiatry 29:463–472
|v 29
|y 2017
999 C 5 |1 KH Jones
|2 Crossref
|9 -- missing cx lookup --
|a 10.1371/journal.pone.0041910
|t PLoS One
|u Jones KH, Ford DV, Jones PA et al (2012) A large-scale study of anxiety and depression in people with multiple sclerosis: a survey via the web portal of the UK MS Register. PLoS One 7:e41910. https://doi.org/10.1371/journal.pone.0041910
|v 7
|y 2012
999 C 5 |1 M Théaudin
|2 Crossref
|9 -- missing cx lookup --
|a 10.1177/1352458515588582
|p 239 -
|t Mult Scler J
|u Théaudin M, Romero K, Feinstein A (2016) In multiple sclerosis anxiety, not depression, is related to gender. Mult Scler J 22:239–244. https://doi.org/10.1177/1352458515588582
|v 22
|y 2016
999 C 5 |1 H Hasselmann
|2 Crossref
|9 -- missing cx lookup --
|a 10.1177/1352458515622826
|p 1476 -
|t Mult Scler
|u Hasselmann H, Bellmann-Strobl J, Ricken R et al (2016) Characterizing the phenotype of multiple sclerosis-associated depression in comparison with idiopathic major depression. Mult Scler 22:1476–1484. https://doi.org/10.1177/1352458515622826
|v 22
|y 2016
999 C 5 |1 F Askari
|2 Crossref
|u Askari F, Ghajarzadeh M, Mohammadifar M et al (2014) Anxiety in patients with multiple sclerosis: association with disability, depression, disease type and sex. Acta Med Iran 52:889–892
|y 2014
999 C 5 |1 B Goretti
|2 Crossref
|9 -- missing cx lookup --
|a 10.1007/s10072-013-1544-0
|p 559 -
|t Neurol Sci
|u Goretti B, Viterbo RG, Portaccio E et al (2014) Anxiety state affects information processing speed in patients with multiple sclerosis. Neurol Sci 35:559–563. https://doi.org/10.1007/s10072-013-1544-0
|v 35
|y 2014
999 C 5 |1 R Leonavičius
|2 Crossref
|9 -- missing cx lookup --
|a 10.2478/s11536-012-0072-2
|p 56 -
|t Cent Eur J Med
|u Leonavičius R, Adomaitienė V (2013) Anxiety and social activities in multiple sclerosis patients. Cent Eur J Med 8:56–61. https://doi.org/10.2478/s11536-012-0072-2
|v 8
|y 2013
999 C 5 |1 RE Boeschoten
|2 Crossref
|9 -- missing cx lookup --
|a 10.1016/j.jns.2016.11.067
|p 331 -
|t J Neurol Sci
|u Boeschoten RE, Braamse AMJ, Beekman ATF et al (2017) Prevalence of depression and anxiety in multiple sclerosis: a systematic review and meta-analysis. J Neurol Sci 372:331–341. https://doi.org/10.1016/j.jns.2016.11.067
|v 372
|y 2017
999 C 5 |1 B Wood
|2 Crossref
|9 -- missing cx lookup --
|a 10.1177/1352458512450351
|p 217 -
|t Muliple Scler J
|u Wood B, van der Mei I, Ponsonby A-L et al (2012) Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis. Muliple Scler J 19:217–224. https://doi.org/10.1177/1352458512450351
|v 19
|y 2012
999 C 5 |1 K Poder
|2 Crossref
|9 -- missing cx lookup --
|a 10.1177/1352458508099143
|p 393 -
|t Mult Scler
|u Poder K, Ghatavi K, Fisk J et al (2009) Social anxiety in a multiple sclerosis clinic population. Mult Scler 15:393–398. https://doi.org/10.1177/1352458508099143
|v 15
|y 2009
999 C 5 |1 H Hoang
|2 Crossref
|9 -- missing cx lookup --
|a 10.1177/1352458515588973
|p 347 -
|t Mult Scler J
|u Hoang H, Laursen B, Stenager EN, Stenager E (2016) Psychiatric co-morbidity in multiple sclerosis: the risk of depression and anxiety before and after MS diagnosis. Mult Scler J 22:347–353. https://doi.org/10.1177/1352458515588973
|v 22
|y 2016
999 C 5 |1 RF Brown
|2 Crossref
|9 -- missing cx lookup --
|a 10.1348/147608308X345614
|p 41 -
|t Psychol Psychother Theory Res Pract
|u Brown RF, Valpiani EM, Tennant CC et al (2009) Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis. Psychol Psychother Theory Res Pract 82:41–56. https://doi.org/10.1348/147608308X345614
|v 82
|y 2009
999 C 5 |1 N Hartoonian
|2 Crossref
|9 -- missing cx lookup --
|a 10.1037/rep0000019
|p 91 -
|t Rehabil Psychol
|u Hartoonian N, Terrill AL, Beier ML et al (2015) Predictors of anxiety in multiple sclerosis. Rehabil Psychol 60:91–98. https://doi.org/10.1037/rep0000019
|v 60
|y 2015
999 C 5 |1 MD Kehler
|2 Crossref
|9 -- missing cx lookup --
|a 10.1007/s10865-008-9186-z
|p 150 -
|t J Behav Med
|u Kehler MD, Hadjistavropoulos HD (2009) Is health anxiety a significant problem for individuals with multiple sclerosis? J Behav Med 32:150–161. https://doi.org/10.1007/s10865-008-9186-z
|v 32
|y 2009
999 C 5 |1 KR Merikangas
|2 Crossref
|9 -- missing cx lookup --
|a 10.1001/archgenpsychiatry.2011.12
|p 241 -
|t Arch Gen Psychiatry
|u Merikangas KR, Jin R, He JP et al (2011) Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 68:241–251
|v 68
|y 2011
999 C 5 |1 MG Carta
|2 Crossref
|9 -- missing cx lookup --
|a 10.1016/j.jad.2013.11.008
|p 255 -
|t J Affect Disord
|u Carta MG, Moro MF, Lorefice L et al (2013) The risk of bipolar disorders in multiple sclerosis. J Affect Disord 155:255–260. https://doi.org/10.1016/j.jad.2013.11.008
|v 155
|y 2013
999 C 5 |2 Crossref
|u Charcot JM (1881) Lectures on the diseases of the nervous system: delivered at la salpêtrière, Vol. 2. New Sydenham Society
999 C 5 |1 A Duncan
|2 Crossref
|9 -- missing cx lookup --
|a 10.1177/1352458514549400
|p 776 -
|t Mult Scler J
|u Duncan A, Malcolm-Smith S, Ameen O, Solms M (2015) Changing definitions of euphoria in multiple sclerosis: a short report. Mult Scler J 21:776–779. https://doi.org/10.1177/1352458514549400
|v 21
|y 2015
999 C 5 |1 SS Cottrell
|2 Crossref
|9 -- missing cx lookup --
|a 10.1136/jnnp.s1-7.25.1
|p 1 -
|t J Neurol Neurosurg Psychiatry
|u Cottrell SS, Kinnier Wilson SA (1926) The affective symptomatology of disseminated sclerosis. A study of 100 cases. J Neurol Neurosurg Psychiatry S1–S7:1–30. https://doi.org/10.1136/jnnp.s1-7.25.1
|v S1–S7
|y 1926
999 C 5 |1 JL Cummings
|2 Crossref
|9 -- missing cx lookup --
|a 10.1212/WNL.48.5_Suppl_6.10S
|p 10S -
|t Neurology
|u Cummings JL (1997) The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology 48:10S-16S. https://doi.org/10.1212/WNL.48.5_Suppl_6.10S
|v 48
|y 1997
999 C 5 |1 A Duncan
|2 Crossref
|9 -- missing cx lookup --
|a 10.1155/2016/5738425
|p 5738425 -
|t Mult Scler Int
|u Duncan A, Malcolm-Smith S, Ameen O, Solms M (2016) The incidence of euphoria in multiple sclerosis : artefact of measure. Mult Scler Int 2016:5738425. https://doi.org/10.1155/2016/5738425
|v 2016
|y 2016
999 C 5 |1 A Iacovides
|2 Crossref
|9 -- missing cx lookup --
|a 10.1097/YCO.0b013e328347341d
|p 336 -
|t Curr Opin Psychiatry
|u Iacovides A, Andreoulakis E (2011) Bipolar disorder and resembling special psychopathological manifestations in multiple sclerosis: a review. Curr Opin Psychiatry 24:336–340. https://doi.org/10.1097/YCO.0b013e328347341d
|v 24
|y 2011
999 C 5 |1 IS Haussleiter
|2 Crossref
|9 -- missing cx lookup --
|a 10.1177/1756285608100325
|p 13 -
|t Ther Adv Neurol Disord
|u Haussleiter IS, Brüne M, Juckel G (2009) Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment. Ther Adv Neurol Disord 2:13–29. https://doi.org/10.1177/1756285608100325
|v 2
|y 2009
999 C 5 |1 J Hanna
|2 Crossref
|9 -- missing cx lookup --
|a 10.1016/j.jns.2016.01.002
|p 200 -
|t J Neurol Sci
|u Hanna J, Feinstein A, Morrow SA (2016) The association of pathological laughing and crying and cognitive impairment in multiple sclerosis. J Neurol Sci 361:200–203. https://doi.org/10.1016/j.jns.2016.01.002
|v 361
|y 2016
999 C 5 |1 M Tarrants
|2 Crossref
|9 -- missing cx lookup --
|a 10.1155/2011/271321
|p 1 -
|t Mult Scler Int
|u Tarrants M, Oleen-Burkey M, Castelli-Haley J, Lage MJ (2011) The impact of comorbid depression on adherence to therapy for multiple sclerosis. Mult Scler Int 2011:1–10. https://doi.org/10.1155/2011/271321
|v 2011
|y 2011
999 C 5 |1 A Erlangsen
|2 Crossref
|9 -- missing cx lookup --
|a 10.1001/jama.2019.21834
|p 444 -
|t J Am Med Assoc
|u Erlangsen A, Stenager E, Conwell Y et al (2020) Association between neurological disorders and death by Suicide in Denmark. J Am Med Assoc 323:444–454. https://doi.org/10.1001/jama.2019.21834
|v 323
|y 2020
999 C 5 |1 A Fidao
|2 Crossref
|9 -- missing cx lookup --
|a 10.1016/j.msard.2020.102620
|t Mult Scler Relat Disord
|u Fidao A, De Livera A, Nag N et al (2021) Depression mediates the relationship between fatigue and mental health-related quality of life in multiple sclerosis. Mult Scler Relat Disord 47:102620. https://doi.org/10.1016/j.msard.2020.102620
|v 47
|y 2021
999 C 5 |1 RS Prakash
|2 Crossref
|9 -- missing cx lookup --
|a 10.1016/j.msard.2019.101399
|t Mult Scler Relat Disord
|u Prakash RS, Schirda B, Valentine TR et al (2019) Emotion dysregulation in multiple sclerosis: impact on symptoms of depression and anxiety. Mult Scler Relat Disord 36:101399. https://doi.org/10.1016/j.msard.2019.101399
|v 36
|y 2019
999 C 5 |1 AM Da Silva
|2 Crossref
|9 -- missing cx lookup --
|a 10.1016/j.jns.2011.03.042
|p 66 -
|t J Neurol Sci
|u Da Silva AM, Vilhena E, Lopes A et al (2011) Depression and anxiety in a Portuguese MS population: associations with physical disability and severity of disease. J Neurol Sci 306:66–70. https://doi.org/10.1016/j.jns.2011.03.042
|v 306
|y 2011
999 C 5 |1 JF Kurtzke
|2 Crossref
|9 -- missing cx lookup --
|a 10.1212/wnl.33.11.1444
|p 1444 -
|t Neurology
|u Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452. https://doi.org/10.1212/wnl.33.11.1444
|v 33
|y 1983
999 C 5 |1 S Mrabet
|2 Crossref
|9 -- missing cx lookup --
|a 10.1016/j.neurol.2014.07.017
|p 700 -
|t Rev Neurol (Paris)
|u Mrabet S, Ben Ali N, Kchaou M, Belal S (2014) Depression in multiple sclerosis. Rev Neurol (Paris) 170:700–702. https://doi.org/10.1016/j.neurol.2014.07.017
|v 170
|y 2014
999 C 5 |1 S Binzer
|2 Crossref
|9 -- missing cx lookup --
|a 10.1212/WNL.0000000000008617
|p E2216 -
|t Neurology
|u Binzer S, McKay KA, Brenner P et al (2019) Disability worsening among persons with multiple sclerosis and depression: a Swedish cohort study. Neurology 93:E2216–E2223. https://doi.org/10.1212/WNL.0000000000008617
|v 93
|y 2019
999 C 5 |1 KA McKay
|2 Crossref
|9 -- missing cx lookup --
|a 10.1212/WNL.0000000000005302
|p e1316 -
|t Neurology
|u McKay KA, Tremlett H, Fisk JD et al (2018) Psychiatric comorbidity is associated with disability progression in multiple sclerosis. Neurology 90:e1316–e1323. https://doi.org/10.1212/WNL.0000000000005302
|v 90
|y 2018
999 C 5 |1 K Honarmand
|2 Crossref
|9 -- missing cx lookup --
|a 10.1007/s00415-010-5736-8
|p 244 -
|t J Neurol
|u Honarmand K, Akbar N, Kou N, Feinstein A (2011) Predicting employment status in multiple sclerosis patients: the utility of the MS functional composite. J Neurol 258:244–249. https://doi.org/10.1007/s00415-010-5736-8
|v 258
|y 2011
999 C 5 |1 C Thielscher
|2 Crossref
|9 -- missing cx lookup --
|a 10.3205/000170
|p 1 -
|t GMS Ger Med Sci
|u Thielscher C, Thielscher S, Kostev K (2013) The risk of developing depression when suffering from neurological diseases. GMS Ger Med Sci 11:1–7. https://doi.org/10.3205/000170
|v 11
|y 2013
999 C 5 |1 SL Minden
|2 Crossref
|9 -- missing cx lookup --
|a 10.1212/WNL.0000000000000013
|p 174 -
|t Neurology
|u Minden SL, Feinstein A, Kalb RC et al (2014) Evidence-based guideline: assessment and management of psychiatric disorders in individuals with MS Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 82:174–181. https://doi.org/10.1212/WNL.0000000000000013
|v 82
|y 2014
999 C 5 |1 YD Fragoso
|2 Crossref
|9 -- missing cx lookup --
|a 10.1136/practneurol-2013-000735
|p 206 -
|t Pract Neurol
|u Fragoso YD, Adoni T, Anacleto A et al (2014) Recommendations on diagnosis and treatment of depression in patients with multiple sclerosis. Pract Neurol 14:206–209. https://doi.org/10.1136/practneurol-2013-000735
|v 14
|y 2014
999 C 5 |1 RA Marrie
|2 Crossref
|9 -- missing cx lookup --
|a 10.1016/j.msard.2017.12.007
|p 9 -
|t Mult Scler Relat Disord
|u Marrie RA, Zhang L, Lix LM et al (2018) The validity and reliability of screening measures for depression and anxiety disorders in multiple sclerosis. Mult Scler Relat Disord 20:9–15. https://doi.org/10.1016/j.msard.2017.12.007
|v 20
|y 2018
999 C 5 |1 D Hind
|2 Crossref
|9 -- missing cx lookup --
|a 10.1186/s12888-016-0931-5
|t BMC Psychiatry
|u Hind D, Kaklamanou D, Beever D et al (2016) The assessment of depression in people with multiple sclerosis: a systematic review of psychometric validation studies. BMC Psychiatry. https://doi.org/10.1186/s12888-016-0931-5
|y 2016
999 C 5 |1 M Hautzinger
|2 Crossref
|t BDI-II beck depressions-inventar revision,
|u Hautzinger M, Keller F, Kühner C (2009) BDI-II beck depressions-inventar revision, 2nd edn. Pearson Assessment & Information GmbH. PsychCorp., Frankfurt
|y 2009
999 C 5 |1 SB Patten
|2 Crossref
|9 -- missing cx lookup --
|a 10.1177/1352458514559297
|p 1064 -
|t Mult Scler J
|u Patten SB, Burton JM, Fiest KM et al (2015) Validity of four screening scales for major depression in MS. Mult Scler J 21:1064–1071. https://doi.org/10.1177/1352458514559297
|v 21
|y 2015
999 C 5 |1 LB Strober
|2 Crossref
|9 -- missing cx lookup --
|a 10.1080/13803395.2015.1063591
|p 722 -
|t J Clin Exp Neuropsychol
|u Strober LB, Arnett PA (2015) Depression in multiple sclerosis: the utility of common self-report instruments and development of a disease-specific measure. J Clin Exp Neuropsychol 37:722–732. https://doi.org/10.1080/13803395.2015.1063591
|v 37
|y 2015
999 C 5 |1 AL Terrill
|2 Crossref
|9 -- missing cx lookup --
|a 10.7224/1537-2073.2014-008
|p 49 -
|t Int J MS Care
|u Terrill AL, Hartoonian N, Beier M et al (2014) The 7-item generalized anxiety disorder scale as a tool for measuring generalized anxiety in multiple sclerosis. Int J MS Care 17:49–56. https://doi.org/10.7224/1537-2073.2014-008
|v 17
|y 2014
999 C 5 |1 S Patrick
|2 Crossref
|9 -- missing cx lookup --
|a 10.1371/journal.pone.0197943
|p 1 -
|t PLoS ONE
|u Patrick S, Connick P (2019) Psychometric properties of the PHQ-9 depression scale in people with multiple sclerosis: a systematic review. PLoS ONE 14:1–12. https://doi.org/10.1371/journal.pone.0197943
|v 14
|y 2019
999 C 5 |1 TM Watson
|2 Crossref
|9 -- missing cx lookup --
|a 10.7224/1537-2073.2013-013
|p 105 -
|t Int J MS Care
|u Watson TM, Ford E, Worthington E, Lincoln NB (2014) Validation of mood measures for people with multiple sclerosis. Int J MS Care 16:105–109. https://doi.org/10.7224/1537-2073.2013-013
|v 16
|y 2014
999 C 5 |1 E Butler
|2 Crossref
|9 -- missing cx lookup --
|a 10.1016/j.msard.2016.10.003
|p 145 -
|t Mult Scler Relat Disord
|u Butler E, Matcham F, Chalder T (2016) A systematic review of anxiety amongst people with multiple sclerosis. Mult Scler Relat Disord 10:145–168. https://doi.org/10.1016/j.msard.2016.10.003
|v 10
|y 2016
999 C 5 |1 A Fischer
|2 Crossref
|9 -- missing cx lookup --
|a 10.1002/brb3.365
|p 1 -
|t Brain Behav
|u Fischer A, Fischer M, Nicholls RA et al (2015) Diagnostic accuracy for major depression in multiple sclerosis using self-report questionnaires. Brain Behav 5:1–8. https://doi.org/10.1002/brb3.365
|v 5
|y 2015
999 C 5 |1 K Honarmand
|2 Crossref
|9 -- missing cx lookup --
|a 10.1177/1352458509347150
|p 1518 -
|t Mult Scler
|u Honarmand K, Feinstein A (2009) Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients. Mult Scler 15:1518–1524. https://doi.org/10.1177/1352458509347150
|v 15
|y 2009
999 C 5 |1 B Litster
|2 Crossref
|9 -- missing cx lookup --
|a 10.7224/1537-2073.2016-004
|p 273 -
|t Int J MS Care
|u Litster B, Fiest KM, Patten SB et al (2016) Screening tools for anxiety in people with multiple sclerosis: a systematic review. Int J MS Care 18:273–281. https://doi.org/10.7224/1537-2073.2016-004
|v 18
|y 2016
999 C 5 |1 M Zimmerman
|2 Crossref
|9 -- missing cx lookup --
|a 10.3109/10673229.2011.614101
|p 219 -
|t Harv Rev Psychiatry
|u Zimmerman M, Galione JN (2011) Screening for bipolar disorder with the mood disorders questionnaire: a review. Harv Rev Psychiatry 19:219–228. https://doi.org/10.3109/10673229.2011.614101
|v 19
|y 2011
999 C 5 |1 MG Carta
|2 Crossref
|9 -- missing cx lookup --
|a 10.1016/j.jad.2014.05.024
|p 192 -
|t J Affect Disord
|u Carta MG, Moro MF, Lorefice L et al (2014) Multiple sclerosis and bipolar disorders: the burden of comorbidity and its consequences on quality of life. J Affect Disord 167:192–197
|v 167
|y 2014
999 C 5 |1 M Sparaco
|2 Crossref
|9 -- missing cx lookup --
|a 10.1007/s00415-019-09426-6
|p 45 -
|t J Neurol
|u Sparaco M, Lavorgna L, Bonavita S (2019) Psychiatric disorders in multiple sclerosis. J Neurol 268(1):45–60
|v 268
|y 2019
999 C 5 |1 M Filser
|2 Crossref
|9 -- missing cx lookup --
|a 10.1016/j.msard.2021.102744
|t Mult Scler Relat Disord
|u Filser M, Baetge SJ, Balloff C et al (2021) Mental symptoms in MS (MeSyMS): development and validation of a new assessment. Mult Scler Relat Disord 49:102744. https://doi.org/10.1016/j.msard.2021.102744
|v 49
|y 2021
999 C 5 |1 RB Schiffer
|2 Crossref
|9 -- missing cx lookup --
|a 10.1191/1352458505ms1162oa
|p 328 -
|t Mult Scler
|u Schiffer RB, Arnett P, Ben-Zacharia A et al (2005) The Goldman Consensus statement on depression in multiple sclerosis. Mult Scler 11:328–337. https://doi.org/10.1191/1352458505ms1162oa
|v 11
|y 2005

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21